Latest Research, Industry, Medical and Scientific News
The American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) has updated their 2017 clinical practice guideline on the surgical treatment of female stress urinary incontinence (SUI). This amendment is based on their review of 24 studies published through February 2022. No changes were made to the patient evaluation and cystoscopy and urodynamics testing sections and only a minor update was made to patient counseling. Read more.
Source: Renal and Urology News, June 16, 2023
Today, Essity, a leading global hygiene and health products company and the maker of TENA incontinence and skin care products, announced the launch of Sensitive CareTM Pads, the first ever bladder weakness pads enriched with its gentle SkinComfort Formula. TENA Sensitive Care Pads are now available in-store and online at retailers across the U.S. Seventy-seven percent of women with bladder weakness claim to experience skin irritation and discomfort while wearing incontinence protection.1 That’s why TENA is addressing intimate skin health with its SkinComfort Formula which incorporates TENA’s skin friendly layer in combination with soft and 100% breathable materials, to help protect intimate skin. Read more.
Source: PRNewswire, June 13, 2023
High compliance users of the new bedwetting alarm, GOGOband, which utilizes real-time heart rate variability analysis and applies artificial intelligence (AI) to create an alarm to wake the user, have a 93 percent dry night rate, according to a study published online April 28 in the Journal of Pediatric Urology. Israel Franco, M.D., from the Yale University School of Medicine in New Haven, Connecticut, and Jon Coble, from GoGoband Inc. in Richmond, Virginia, evaluated a new bedwetting alarm, GOGOband, and assessed the efficacy in the first 18 months of use. All 54 individuals (mean age, 10.1 years) who used the system for more than 30 nights from Jan. 1, 2020, to June 2021, were included. Read more.
Source: Health Day, May 30, 2023
Axena Health, Inc. (Axena Health), a women’s health medical device company focused on scalable treatments for female pelvic health, announced today a large-scale study that will investigate the burdens of incontinence on women in low- and middle-income countries to support equitable access to treatment. The first-of-its-kind study will examine how women could access treatment within local healthcare delivery systems and in a manner that accommodates cultural norms. Study results will be available in late 2023 and will inform the development of new treatment options based on the Leva® Pelvic Health System, a digital health treatment for urinary incontinence (UI) with published studies supporting its effectiveness, including durable, long-term symptom relief. Read more.
Source: Yahoo! Finance, May 19, 2023
Megola, Inc. (“MGON”, “Company”) a Consortium Group of Health Technologies and Eco-Friendly Product Lines announced the successful completion of its Pilot Scale-up Field Testing with its patent-pending Odor Control (SAPs) for Baby Diapers, Adult Incontinence and Feminine Hygiene Products. The odor control personal hygiene products were provided to a group of incontinent human volunteers in the USA. Superabsorbent Polymer granules (SAP) are used annually in diapers and pads of all types, in a global industry with an annual turnover of more than $100 billion. “It’s been a long time coming but controlling embarrassing odors from incontinence garments and feminine hygiene products is about to become a reality at last….” Read more.
Source: StreetInsider.com, May 8, 2023
The most common symptom of an overactive bladder is a sudden, uncontrolled need or urge to urinate; followed by the need to urinate excessively throughout the day and night, independent of fluid intake. In women, causes of overactive bladder are varied, but the common consequence, beyond the physical manifestations, are frustration and embarrassment. While medications designed to relax the bladder remain a frontline treatment option, research continues to show the potential of nonpharmaceutical options – including acupuncture. Case in point: a 2023 research review that concludes acupuncture is effective and safe for treating overactive bladder. Read more.
Source: Acupunture Today, May/June 2023